Concepedia

Philmore Robertson

PR

Statistics

Publications

33

Citations

1.6K

H-Index

21

Active since

1980

Affiliations

Avalon Pharma (United States)(Current)

Teva Pharmaceuticals (United States)

Duke Medical Center

Oncode Institute

The Netherlands Cancer Institute

Philmore Robertson is an author at Avalon Pharma (United States) specializing in pharmacology, pharmacokinetics, and clinical pharmacology.

Publications per year

1980–2016

33

Publications

33

Effects of Prototypical Microsomal Enzyme Inducers on Cytochrome P450 Expression in Cultured Human Hepatocytes

Ajay Madan, Richard Graham, Kathleen Carroll et al. · Drug Metabolism and Disposition · 2003 · 337 citations

, , +17

Armodafinil and Modafinil Have Substantially Different Pharmacokinetic Profiles Despite Having the Same Terminal Half-Lives

Mona Darwish, Mary Kirby, Edward T. Hellriegel et al. · Clinical Drug Investigation · 2009 · 256 citations

, , +11

In Vitro Inhibition and Induction of Human Hepatic Cytochrome P450 Enzymes by Modafinil

Philmore Robertson, Heleen H. DeCory, Ajay Madan et al. · Drug Metabolism and Disposition · 2000 · 115 citations

, , +16

Absolute and Relative Bioavailability of Fentanyl Buccal Tablet and Oral Transmucosal Fentanyl Citrate

Mona Darwish, Mary Kirby, Philmore Robertson et al. · The Journal of Clinical Pharmacology · 2007 · 101 citations

, , +17

Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor

John L. Marshall, Hedy L. Kindler, John F. Deeken et al. · Investigational New Drugs · 2004 · 95 citations

, , +6

1–5 of 33